AHF Initiates Statewide Campaign Calling for Full Reinstatement of Florida’s AIDS Drug Assistance Program
The AIDS Healthcare Foundation (AHF) has launched a statewide public awareness campaign urging Ron DeSantis and the Florida Legislature to take immediate and permanent action to restore the state’s AIDS Drug Assistance Program (ADAP) before temporary funding expires on June 30. The initiative reflects growing concern among public health advocates that thousands of Floridians living with HIV could soon lose access to critical, life-sustaining medications and healthcare support.
ADAP plays a central role in Florida’s HIV response infrastructure by providing access to antiretroviral medications and insurance premium assistance for individuals who cannot otherwise afford treatment. For many patients, the program is not simply a support mechanism—it is the difference between consistent care and severe health deterioration. Medical experts widely recognize that when individuals adhere to HIV treatment, they can achieve viral suppression, meaning the virus becomes undetectable in their blood and cannot be transmitted to others. In this way, ADAP is not only a treatment program but also a cornerstone of public health prevention efforts.
However, in March, the Florida Department of Health implemented sweeping changes to the program that significantly reduced access. More than 11,000 Floridians were affected when eligibility criteria were tightened, leaving many without coverage. In addition, the state eliminated insurance premium assistance, a benefit that had helped patients maintain broader healthcare access beyond HIV-specific medications. Compounding these challenges, the widely prescribed HIV medication Biktarvy was removed from the program’s drug formulary, limiting treatment options for patients and clinicians alike.
These changes sparked immediate concern among advocacy organizations, healthcare providers, and policymakers, prompting a bipartisan response from the Florida Legislature. Lawmakers unanimously passed House Bill 697, allocating $31 million in emergency funding to temporarily stabilize the program. Governor DeSantis subsequently signed the measure into law, ensuring that ADAP services could continue in the short term. While this action provided a temporary reprieve, advocates warn that it does not address the underlying issue.
Without permanent funding included in the state’s fiscal year 2026–2027 budget, the same restrictions are scheduled to return on July 1. This looming deadline has intensified calls for long-term solutions, as thousands of patients face the risk of losing access to essential medications and support services once again.
Esteban Wood, Director of Advocacy, Legislative Affairs, and Community Engagement at AHF, emphasized the urgency of the situation. He noted that ADAP has consistently demonstrated its effectiveness in improving patient outcomes, reducing new HIV infections, and lowering overall healthcare costs. According to Wood, the program represents a rare example of a public health initiative that not only saves lives but also delivers economic value by preventing costly hospitalizations and advanced disease progression.
Wood further pointed out that the Legislature’s unanimous support for emergency funding underscores the nonpartisan nature of the issue. He argued that the same level of consensus should now be applied to securing permanent funding, ensuring that patients are not subjected to recurring disruptions in care. With approximately 12,000 Floridians depending on the program, he stressed that delays in action could have serious and immediate consequences.
To amplify its message, AHF’s campaign is being deployed across multiple media channels, including cable television, radio, digital platforms, and print publications. Running through mid-May, the campaign aims to mobilize public support and encourage direct engagement with state leaders. Floridians are being urged to contact Governor DeSantis and their local representatives to advocate for full restoration of ADAP funding in the upcoming state budget.
The campaign also highlights the broader implications of reduced access to HIV treatment. Interruptions in medication can lead to viral rebound, increased risk of transmission, and the development of drug resistance, all of which pose challenges not only for individual patients but also for the healthcare system as a whole. By contrast, sustained access to treatment supports long-term viral suppression, improves quality of life, and contributes to the broader goal of ending the HIV epidemic.
AHF’s involvement in this issue reflects its longstanding commitment to expanding access to HIV care and treatment on a global scale. As the world’s largest nonprofit provider of HIV/AIDS healthcare services, the organization currently supports more than 2.9 million individuals across 50 countries. Its work spans the United States, Africa, Latin America and the Caribbean, the Asia-Pacific region, and Eastern Europe, encompassing both clinical services and advocacy initiatives aimed at addressing structural barriers to care.
In recognition of its contributions to public health and social justice, AHF was awarded the MLK Jr. Social Justice Award in January 2025. This honor, presented by The King Center, represents one of the highest distinctions for organizations working to advance equity and justice. The award underscores AHF’s role not only as a healthcare provider but also as a leading voice in the fight for health equity and human rights.
As the June 30 deadline approaches, the outcome of this advocacy campaign may prove critical in determining the future of HIV care access in Florida. For thousands of patients, the stakes are exceptionally high, with uninterrupted treatment serving as the foundation for both individual health and broader public health progress. Through its campaign, AHF is seeking to ensure that ADAP remains a stable and fully funded resource, capable of meeting the needs of those who rely on it now and in the years ahead.
Source Link:https://www.businesswire.com/
